Financial reports
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Completion of Acquisition or Disposition of Assets
11 Apr 24
8-K
Other Events
11 Apr 24
8-K
Other Events
9 Apr 24
8-K
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
14 Mar 24
8-K
Departure of Directors or Certain Officers
19 Jan 24
8-K
Other Events
11 Dec 23
8-K
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
6 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
8-K
Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
9 Nov 23
8-K
Other Events
3 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
14 Mar 24
S-8
Registration of securities for employees
17 Mar 23
S-3
Shelf registration
1 Jul 22
S-8
Registration of securities for employees
17 Mar 22
S-8
Registration of securities for employees
2 Jul 21
424B4
Prospectus supplement with pricing info
21 Jun 21
S-1/A
IPO registration (amended)
15 Jun 21
8-A12B
Registration of securities on exchange
14 Jun 21
S-1/A
IPO registration (amended)
14 Jun 21
S-1
IPO registration
28 May 21
Other
EFFECT
Notice of effectiveness
14 Jul 22
CORRESP
Correspondence with SEC
11 Jul 22
UPLOAD
Letter from SEC
8 Jul 22
EFFECT
Notice of effectiveness
18 Jun 21
CERT
Certification of approval for exchange listing
17 Jun 21
SEC STAFF
SEC staff action: Order
17 Jun 21
CERT
Certification of approval for exchange listing
16 Jun 21
CERT
Certification of approval for exchange listing
16 Jun 21
CORRESP
Correspondence with SEC
15 Jun 21
CORRESP
Correspondence with SEC
15 Jun 21
Ownership
SC 13G
Bain Capital Life Sciences Opportunities III, LP
25 Apr 24
4
Gregory Russotti
24 Apr 24
SC 13G
Boxer Capital, LLC
22 Apr 24
144
Notice of proposed sale of securities
22 Apr 24
SC 13G
Casdin Capital, LLC
18 Apr 24
SC 13D/A
Casdin Capital, LLC
8 Apr 24
144
Notice of proposed sale of securities
20 Mar 24
4
Brent Pfeiffenberger
18 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24